Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
3000
Trial Sponsor
Clinical Trial Start Date
2024
0Primary Completion Date
2027
0Study Completion Date
2027
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 30
Participating Facility
Official Name
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)0
Last Updated
June 3, 2024
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Other attributes
Intervention Treatment
Tirzepatide0
Placebo0
Study summary
The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 weeks and may include up to 23 visits.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
